GlassScriptPhysician profile
Tara Lynn Baum
NPI 1275710477
$2,138.63
in general payments reported to CMS, 2019-2025
30 companies · $421 in 2025
The $421 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $246 · 2021: $279 · 2022: $202 · 2023: $272 · 2024: $553 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.96 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.65 | 2019-2025 | Qulipta |
| Astellas Pharma US INC | $361.91 | 2023-2025 | Veozah |
| Biogen, INC. | $231.33 | 2024-2025 | Zurzuvae |
| Caldera Medical, INC | $153.43 | 2024 | Desara |
| Exeltis, USA INC. | $117.02 | 2021-2025 | Slynd |
| Organon LLC | $71.48 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $57.52 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $56.30 | 2019-2021 | |
| Hologic Sales and Service, LLC | $47.31 | 2024 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Merck Sharp & Dohme LLC | $38.24 | 2019-2020 | |
| Olympus America INC. | $33.23 | 2020 | |
| Amgen INC. | $27.05 | 2019-2021 | |
| Baxter Healthcare | $24.03 | 2022 | |
| Covidien LP | $23.38 | 2019 | |
| Myovant Sciences INC. | $22.63 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $22.29 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $21.51 | 2023 | Pico |
| Roche Diagnostics Corporation | $16.94 | 2021 | |
| Minerva Surgical, INC | $16.15 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.94 | 2025 | |
| Teleflex LLC | $15.89 | 2025 | Quikclot |
| Therapeuticsmd, INC. | $15.29 | 2020 | |
| Boston Scientific Corporation | $15.26 | 2022 | |
| Novo Nordisk INC | $15.07 | 2020 | |
| Agile Therapeutics, INC. | $15.00 | 2021 | |
| Pfizer INC. | $13.69 | 2023 | |
| Convatec INC. | $13.66 | 2024 | |
| Mayne Pharma Commercial LLC | $13.32 | 2023 | |
| Lilly USA, LLC | $12.56 | 2020 | |
| Sage Therapeutics, LLC | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.